July 28, 2025 · Form 4 insider transaction
Mayersohn Joel David bought 21,228 shares of Citius Oncology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 10 days after the transaction.
The shares were acquired through a distribution in kind to limited partners of 10XYZ Holdings, which was the Sponsor of TenX Keane Acquisition ("TenX"), the legacy entity of Citius Oncology, Inc.